Regenerative and Stem Cell Clinics | Longevity Forward Science

Focus	Cellular therapy
What It Covers	Adipose or umbilical-derived stem cell injections or infusions Exosome injections Platelet-rich plasma for joints, skin, or hair Young plasma or plasma exchange marketed for rejuvenation Peptide protocols Medical tourism packages outside U.S. jurisdiction
Typical Cost	$5,000 to $50,000 per treatment
Evidence Level	Unsupported for aging: the underlying research is real, but no cellular product is approved for aging and none has completed a trial showing benefit
Regulatory Status	FDA consumer alert covers stem cell and exosome products; most marketed products are unapproved and enforcement actions have followed
Watchouts	The same product offered for aging, arthritis, autism, and neurological disease Testimonials in place of trials FDA-registered used to imply FDA-approved Patients paying to join something called a study Treatment delivered abroad to avoid domestic oversight
Questions To Ask	Is this product FDA-approved, or under an investigational new drug application? Which completed trial showed benefit and where is it published? What adverse events have occurred with this product? Why is it available here but not at an academic medical center?

Parallel Coverage

Related Resources

This profile connects back into the article, glossary, and FAQ layers so overlapping coverage stays discoverable instead of fragmented.

A guide to the biological processes researchers believe drive aging at the cellular level, and why they matter for longevity science.

How longevity medicine differs from conventional healthcare, what it typically involves, and where the evidence stands.

What longevity clinics offer, how they differ from traditional primary care, and questions worth asking before enrolling in one.